Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
2020 ◽
Vol 31
(3)
◽
pp. 442
N.W. Clarke
◽
A. Ali
◽
F.C. Ingleby
◽
A. Hoyle
◽
C.L. Amos
◽
...
2019 ◽
Vol 30
(12)
◽
pp. 1992-2003
◽
N.W. Clarke
◽
A. Ali
◽
F.C. Ingleby
◽
A. Hoyle
◽
C.L. Amos
◽
...
2000 ◽
Vol 47
(3)
◽
pp. 617-627
◽
Mack Roach
◽
Jiandong Lu
◽
Miljenko V Pilepich
◽
Sucha O Asbell
◽
Mohammed Mohuidden
◽
...
2018 ◽
Vol 200
(2)
◽
pp. 244-245
2001 ◽
Vol 5
(2)
◽
pp. 205
◽
M Roach
◽
J Lu
◽
M.V Pilepich
◽
S.O Asbell
◽
M Mohuidden
◽
...
2006 ◽
Vol 175
(4S)
◽
pp. 65-65
Ashutosh K. Tewari
◽
George Divine
◽
Mani Menon
2004 ◽
Vol 171
(4S)
◽
pp. 121-121
Ashutosh Tewari
◽
Mazen Hasan
◽
George Devine
◽
Mani Menon
2008 ◽
Vol 97
(7)
◽
pp. 583-591
◽
Liqian Liu
◽
Ann L. Coker
◽
Xianglin L. Du
◽
Janice N. Cormier
◽
Charles E. Ford
◽
...
2017 ◽
Vol 71
(6)
◽
pp. 907-912
◽
Won Sik Ham
◽
Heather J. Chalfin
◽
Zhaoyong Feng
◽
Bruce J. Trock
◽
Jonathan I. Epstein
◽
...
1994 ◽
Vol 28
(1)
◽
pp. 39-45
◽
Gerald E. Hanks
◽
John M. Krall
◽
Alexandra L. Hanlon
◽
Sucha O. Asbell
◽
Miljenko V. Pilepich
◽
...
Close
Export Citation Format
Close
Share Document
Close